💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Immunomedics, Inc. (IMMU)
« Back to company indexIMMU Chatter Timeline
Stock Ticker for IMMU
Most Active Tweeters for IMMU
| User | Tweets |
|---|---|
| @stockmktgenius | 3 |
| @FlashAlert_me | 3 |
| @haodongvli | 2 |
| @HealthcareBeat | 2 |
| @VisualStockRSRC | 2 |
Recent Tweets for IMMU
 |
@mediasentiment $IMMU new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 354 October 16th 2020, 5:10am |
 |
@ThisLincolnian Immunomedics $IMMU Reaches New 52-Week High at $87.69 https://t.co/scYn3YIlT3 October 16th 2020, 5:10am |
 |
@dailypoliticaln Immunomedics $IMMU Reaches New 52-Week High at $87.69 https://t.co/OzsxvRJt6S October 16th 2020, 5:10am |
 |
@WeekHerald Immunomedics, Inc. $IMMU Expected to Announce Quarterly Sales of $41.73 Million https://t.co/y0lRID7qZz October 15th 2020, 10:10pm |
 |
@andrewstepner @given2tweet Is this still applicable on $IMMU with HSR expiring... get paid a bit quicker tendering than with acqu… https://t.co/6YRrhsFVlU October 15th 2020, 9:10pm |
 |
@BiotechTo $IMMU merg/arb still good yield https://t.co/EsXbJdmzxc October 15th 2020, 8:10am |
 |
@WatchlistN Immunomedics, Inc. $IMMU Receives $45.38 Average Target Price from Brokerages https://t.co/gVWHMAHE5G October 15th 2020, 6:10am |
 |
@MSS1992BIO @business My guess was that they would buy $immu instead of $gild given how tecentriq flunked in TNBC. Instead... they still are stingy. October 15th 2020, 3:10am |
 |
@Traderofstocks1 $IMMU https://t.co/XGIBHO4G8P October 15th 2020, 2:10am |
 |
@VisualStockRSRC $IMMU - Amended Tender Offer Statement by Third Party (sc To-t/a) https://t.co/aLru36a47U October 13th 2020, 5:10pm |
 |
@FlashAlert_me $IMMU [15s. delayed] filed form SC TO-T/A on October 13, 17:18:21 https://t.co/JcF4PJcu62 October 13th 2020, 5:10pm |
|
@FlashAlert_me $IMMU [15s. delayed] filed form SC 14D9/A on October 13, 17:16:49 https://t.co/drK7qdMl9A October 13th 2020, 5:10pm |
 |
@SharonAConklin $IMMU $GILD Immunomedics granted Orphan Drug Designation from FDA for Trodelvy for the treatment of adult and pedi… https://t.co/eZdwNJHFTJ October 13th 2020, 8:10am |
 |
@AmericanBanking Immunomedics, Inc. $IMMU Receives Consensus Rating of “Hold” from Brokerages https://t.co/kQ5YH6kaVa #stocks October 12th 2020, 7:10pm |
 |
@HealthcareBeat Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma $IMMU https://t.co/Ovtqm8T8HJ October 12th 2020, 6:10pm |
 |
@stockmktgenius $IMMU Immunomedics, Inc. - Comm Leading stock #BreakOutWatch Recent close 86.10 Liquidity: $305M https://t.co/YqoKLwtR2o October 12th 2020, 6:10pm |
 |
@MarcJacksonLA $IMMU Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma https://t.co/ksfpV5Qhun October 12th 2020, 3:10pm |
 |
@getbillasap I put about 1/3rd of my wife's checking account into $IMMU about 2 weeks ago and just tendered the shares. When I l… https://t.co/70ldNjcCYN October 12th 2020, 2:10pm |
 |
@haodongvli @Kevvy_Kaye wish I know, I am forced to cash out on $IMMU $MYOK and paying long term capital gains October 12th 2020, 1:10pm |
|
@HealthcareBeat Immunomedics's trodelvy nabs Orphan Drug tag for brain tumor in the U.S. $IMMU https://t.co/sA8uWLUNXh October 12th 2020, 10:10am |
 |
@Briefingcom $IMMU: Immunomedics granted Orphan Drug Designation from FDA for Trodelvy for the treatment of adult and pediatric.… https://t.co/GXjQSQ50p6 October 12th 2020, 10:10am |
 |
@HottestStockNow FDA Grants orphan drug designation to $IMMU 's Trodelvy for adult and pediatric glioblastoma #Immunomedics… https://t.co/Fg4JxIJIjF October 12th 2020, 8:10am |
 |
@quant_data Immunomedics Announces FDA Orphan Drug Designation Of Trodelvy For Adult And Pediatric Glioblastoma Related Tickers: $IMMU October 12th 2020, 8:10am |
 |
@KillerStockCall $IMMU (#DollarStock, Large Spread) Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pe… https://t.co/Kvkcw0eauC October 12th 2020, 8:10am |
 |
@allymrowe RT @DeItaone: Immunomedics: FDA Grants Orphan Drug Designation of Trodelvy for Adult and Pediatric Glioblastoma $IMMU October 12th 2020, 8:10am |
|
@VisualStockRSRC $IMMU - Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma https://t.co/G4F6GdhVg0 October 12th 2020, 8:10am |
 |
@sbwcws Immunomedics announces orphan drug designation for Trodelvy $IMMU October 12th 2020, 8:10am |
|
@FlashAlert_me $IMMU [15s. delayed]: Issued Press Release on October 12, 08:00:00: Immunomedics Announces FDA Orphan Drug Designat… https://t.co/koh1tqb2VJ October 12th 2020, 8:10am |
 |
@DeItaone Immunomedics: FDA Grants Orphan Drug Designation of Trodelvy for Adult and Pediatric Glioblastoma $IMMU October 12th 2020, 8:10am |
 |
@TheTradeXchange $IMMU: Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma October 12th 2020, 8:10am |
 |
@stock_titan $IMMU Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma https://t.co/J4JCallf4O October 12th 2020, 8:10am |
 |
@1GREAT_TRADE Here's an $IMMU flag pole set up from long ago. All patterns I have long applied in my trades, probability is high.… https://t.co/dJ9rSKMCXL October 10th 2020, 10:10pm |
 |
@ChartMill $IMMU is currently trading near its 52 week high, which is a good sign. https://t.co/u9ZK7Aww1r https://t.co/2fWg3QCfEy October 10th 2020, 1:10pm |
 |
@SurrogateCap @MarkC53916729 @RVH_Investing I guess I don't consider this as a breakaway gap. $immu is a good example of one Ye… https://t.co/eIev3vps7R October 10th 2020, 7:10am |
|
@WatchlistN Immunomedics, Inc. $IMMU Expected to Announce Quarterly Sales of $41.73 Million https://t.co/OW4szcl47R October 10th 2020, 5:10am |
 |
@Biotech2050 RT @grpetersen1: $IMMU Save the World! https://t.co/ec0l40D0NA October 9th 2020, 2:10pm |
 |
@grpetersen1 $IMMU Save the World! https://t.co/ec0l40D0NA October 9th 2020, 2:10pm |
|
@andrewstepner @given2tweet Do you happen to know if any advantage to $IMMU tendering shares (as opposed to waiting for it to close on its own)? October 9th 2020, 11:10am |
 |
@smelky_kid @gcbioinv $icpt. and don’t forget the Goldman Sachs analyst that slapped a 5 dollar price target in $IMMU 2 weeks b… https://t.co/e46FU15YBA October 8th 2020, 3:10pm |
|
@smelky_kid @adamfeuerstein Remember Adams history w $IMMU. Generally speaking, he bashes on purpose and then the FDA approves… https://t.co/m18wvi5I2w October 8th 2020, 3:10pm |
|
@sbwcws Immunomedics granted orphan designation for sacituzumab govitecan $IMMU October 8th 2020, 11:10am |
 |
@tsilver_apex $IMMU sacituzumab govitecan granted orphan drug designation for the treatment of malignant glioma https://t.co/R8bSpy2l7D October 8th 2020, 11:10am |
|
@grpetersen1 $CLRB Oppenheimer, 5-star analyst Kevin DeGeeter called $IMMU buyout, he predicts CLRB as a buyout candidate as we… https://t.co/j8cuTVITvR October 8th 2020, 10:10am |
|
@stockmktgenius $IMMU Immunomedics, Inc. - Comm Leading stock #BreakOutWatch Recent close 85.36 Liquidity: $254M https://t.co/YqoKLwtR2o October 7th 2020, 11:10pm |
|
@gr8t_just $immu does this deal with $gild have regulatory risk? GILD already raised the dough so no financing risk to explain the spread. October 7th 2020, 3:10pm |
 |
@ThomasPhilipp6 RT @StevenReznik: $TGTX look at their market cap and then look at $IMMU take a look at both pipelines and then judge for yourself if there… October 7th 2020, 2:10pm |
 |
@s6m6w6 @ripster47 $immu raised money in late April 2020 and were recently bought out. $auph is well positioned October 7th 2020, 1:10pm |
|
@StevenReznik $TGTX look at their market cap and then look at $IMMU take a look at both pipelines and then judge for yourself if… https://t.co/5pJFG04rTB October 7th 2020, 9:10am |
 |
@Gambiste1 RT @tweetietat: Pancreatic Cancer results: NK =22% CR vs. Trodelvy $IMMU / (Gilead) = 4% CR (NK 9 patients; Trodelvy 10 patients) IMMU pu… October 6th 2020, 7:10pm |
|
@tweetietat Pancreatic Cancer results: NK =22% CR vs. Trodelvy $IMMU / (Gilead) = 4% CR (NK 9 patients; Trodelvy 10 patients)… https://t.co/qmmeQsTvVg October 6th 2020, 6:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
